Vitamin D pathway polymorphisms in relation to mammographic breast density

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 9, 2008, Pages 2505-2508

  Diorio, Caroline ^a,c,d   Sinotte, Marc ^c,d   Brisson, Jacques ^c,d   Bérube, Sylvie ^d   Pollak, Michael ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BREAST; BREAST CANCER; CANCER RISK; CAUCASIAN; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INTERVIEW; MAMMOGRAPHIC BREAST DENSITY; MAMMOGRAPHY; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 53349153173     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0493     Document Type: Article

References (21)

1. Welsh J. Vitamin Dand breast cancer: insights from animal models. Am J Clin Nutr 2004;80:1721-4S.
2. Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2006;15:1427-37.
3. Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B. Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev 2007;16:929-33.
4. Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 2008;29:93-9.
5. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
6. Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr 2006;136:887-92.
7. Rowling MJ, Kemmis CM, Taffany DA, Welsh J. Megalin-mediated endocytosis of vitamin Db inding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr 2006;136:2754-9.
8. Diorio C, Pollak M, Byrne C, et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005;14:1065-73.
9. Xiong DH, Xu FH, Liu PY, et al. Vitamin D receptor gene polymorphisms are linked to and associated with adult height. J Med Genet 2005;42:228-34.
10. Stram DO, Leigh Pearce C, Bretsky P, et al. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003;55:179-90.
11. Trabert B, Malone KE, Daling JR, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 2007;9:R84.
12. Abbas S, Nieters A, Linseisen J, et al. Vitamin Dreceptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 2008;10:R31.
13. McCullough ML, Stevens VL, Diver WR, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 2007;9:R9.
14. VandeVord PJ, Wooley PH, Darga LL, Severson RK, Wu B, Nelson DA. Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 2006;100:103-7.
15. Ursin G, Ma H, Wu AH, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003;12:332-8.
16. Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations between polymorphisms in the vitamin Drecep tor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2335-9.
17. Diorio C, Brisson J, Berube S, Pollak M. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 2008;17:880-8.
18. Welsh J, Targets of vitamin Drecep tor signaling in the mammary gland. J Bone Miner Res 2007;22 Suppl 2:V86-90.
19. d'Alesio A, Garabedian M, Sabatier JP, et al. Two single-nucleotide polymorphisms in the human vitamin Drecep tor promoter change protein-DNA complex formation and are associated with height and vitamin Dstatus in adolescent girls. Hum Mol Genet 2005;14:3539-48.
20. Jennings CE, Owen CJ, Wilson V, Pearce SH. A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. J Mol Endocrinol 2005;34:859-63.
21. Speeckaert M, Huang G, Delanghe JR, Taes YE, Biological and clinical aspects of the vitamin Dbinding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006;372:33-42.